| Literature DB >> 28462118 |
Moon-Hyon Hwang1,2, Sewon Lee2,3.
Abstract
Insulin resistance associated with metabolic syndrome and Type 2 diabetes mellitus is an epidemic metabolic disorder, which increases the risk of cardiovascular complications. Impaired vascular endothelial function is an early marker for atherosclerosis, which causes cardiovascular complications. Both experimental and clinical studies indicate that endothelial dysfunction in vasculatures occurs with insulin resistance. The associated physiological mechanisms are not fully appreciated yet, however, it seems that augmented oxidative stress, a physiological imbalance between oxidants and antioxidants, in vascular cells is a possible mechanism involved in various vascular beds with insulin resistance and hyperglycemia. Regardless of the inclusion of resistance exercise, aerobic exercise seems to be beneficial for vascular endothelial function in both large conduit and small resistance vessels in both clinical and experimental studies with insulin resistance. In clinical cases, aerobic exercise over 8 weeks with higher intensity seems more beneficial than the cases with shorter duration and lower intensity. However, more studies are needed in the future to elucidate the physiological mechanisms by which vascular endothelial function is impaired in insulin resistance and improved with aerobic exercise.Entities:
Keywords: aerobic exercise; atherosclerosis; diabetes mellitus; metabolic syndrome; resistance exercise
Year: 2016 PMID: 28462118 PMCID: PMC5390417 DOI: 10.1016/j.imr.2016.06.001
Source DB: PubMed Journal: Integr Med Res ISSN: 2213-4220
Effect of exercise training on vascular endothelial function in individuals with IR
| Disease | Age (y) | Sex | Ex | Ex intensity | Ex frequency | Ex time | Vessel studied | Conclusion | Refs |
|---|---|---|---|---|---|---|---|---|---|
| IR (9) | 37 | Both | Aerobic | Moderate | 3–4 d/wk | 20–40 min | Conduit | ACh-induced vasorelaxation↑ | |
| T2DM (16) | – | – | Aerobic and | Moderate | 3 d/wk | 1 h | Conduit | Flow-mediated vasodilation↑ | |
| T2DM (38) | 62 | Both | Aerobicand | Moderate | 3–5 d/wk | 75 min | Conduit | Flow-mediated vasodilation↑ | |
| T2DM (43) | 62 | Both | Aerobic | Moderate | 3 d/wk | 30–40 min | Conduit | Flow-mediated vasodilation↑ | |
| T2DM (42) | 67 | Both | Aerobicand | Moderate | 3–5 d/wk | 20–30 min | Conduit | Flow-mediated vasodilation = | |
| T2DM (59) | 63 | Both | Aerobic | Moderate | 3 d/wk | 30 min | Micro (skin) | ACh-induced vasorelaxation = | |
| T2DM (18) | 60 | Male | Aerobic and | Moderate | 3 d/wk | 1 h | Conduit | Flow-mediated vasodilation = | |
| MS (29) | 40–60 | Male | Aerobic | Moderate | 3 d/wk | 50 min | Conduit | Flow-mediated vasodilation↑ | |
| MS (28) | — | Both | Aerobic | Moderate | 3 d/wk | 40–47min | Conduit | Flow-mediated vasodilation↑ | |
| MS (32) | 50–55 | Both | Aerobic | Moderate | 3 d/wk | 40–47 min | Conduit | Flow-mediated vasodilation↑ | |
| MS (38) | 50–70 | Both | Aerobicand | Not addressed | 4–5 d/wk | 90 min | Micro (skin) | ACh-induced vasorelaxation↑ |
ACh, acetylcholine; Ex, exercise; IR, insulin resistance; MS, metabolic syndrome; T2DM, Type 2 diabetes mellitus; ↑, increase; ↑↑, more increase; =, no change.
Effect of insulin resistance or metabolic syndrome on vasorelaxation in various vasculatures in experimental animal models
| Animals | Sex | Disease | Vessel studied | Conclusion | Refs |
|---|---|---|---|---|---|
| C57BL/6 mice | Female | IR | Coronary arteriole | ACh–induced vasorelaxation ↓ | |
| C57BL/6J mice | Female | IR | Aorta | ACh-induced vasorelaxation ↓ | |
| Femoral artery | ACh-induced vasorelaxation = | ||||
| C57BL/6J mice | Male | IR | Aorta | ACh–induced vasorelaxation = | |
| C57BL/6J mice | Male | IR | Aorta | ACh-induced vasorelaxation ↓ | |
| C57BL/6J mice | Male | IR | Femoral artery | ACh-induced vasorelaxation ↓ | |
| C57BL/6J mice | Male | IR | Coronary artery | ACh-induced vasorelaxation = | |
| Aorta | ACh-induced vasorelaxation ↓ | ||||
| C57BL/6J mice | Male | IR | Aorta | ACh-induced vasorelaxation = | |
| C57BL/6J mice | Male | MS | Superior mesenteric | ACh-induced vasorelaxation ↓ | |
| C57BL/6J mice | Male | IR | Mesentery arteriole | ACh-induced vasorelaxation = | |
| C57BL/6J mice | Male | IR | Gracilis artery | ACh-induced vasorelaxation ↓ | |
| C57BL/6J mice | Not specified | Obesity | Femoral artery | ACh-induced vasorelaxation ↓ | |
| C57BL/6J mice | Not specified | IR | Mesentery arteriole | Insulin-induced vasorelaxation ↓ | |
| B6D2F1 mice | Male | IR by aging | Artery from epididymal white | ACh-induced vasorelaxation ↓ | |
| New Zealand Obese Mice | Male | MS | Mesenteric artery | ACh-induced vasorelaxation ↓ | |
| Ossabaw swine | Male | MS | LAD | Coronary blood flow ↓ |
ACh, acetylcholine; IR, insulin resistance; LAD, left anterior descending; MS, metabolic syndrome; ↓, decrease; =, no change.
Effect of exercise on vascular dysfunction induced by IR or MS in experimental animal models
| Animals | Sex | Disease | Vessel studied | Type of EX | Ex effect | Refs |
|---|---|---|---|---|---|---|
| C57BL/6 mice | Female | IR | Coronary arteriole | Voluntary wheel running | ACh-induced vasorelaxation ↑ | |
| C57BL/6 mice | Male | IR | Aorta | Treadmill exercise | ACh-induced vasorelaxation ↑ | |
| OLETF rats | Male | IR | Arteriole from | Voluntary wheel running | Insulin-induced vasorelaxation ↑ | |
| OLETF rats | Male | IR | Gastrocnemius feed artery | Voluntary wheel running | ACh-induced vasorelaxation ↑ | |
| Soleus feed artery | ACh-induced vasorelaxation = | |||||
| Low intrinsic aerobic treadmill running capacity rats | Male | Metabolic syndrome | Aorta | Continuous moderate-intensity exercise, | ACh-induced vasorelaxation ↑ |
ACh, acetylcholine; Ex, exercise; IR, insulin resistance; MS, metabolic syndrome; OLETF, Otsuka Long–Evans Tokushima Fatty; ↑, increase; =, no change.